Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)
- Licence status
- Active substances
- Pneumococcal polysaccharide serotype 1, Pneumococcal Polysaccharide Serotype 3, Pneumococcal polysaccharide serotype 4, Pneumococcal polysaccharide serotype 5, Pneumococcal Polysaccharide Serotype 6A, Pneumococcal polysaccharide serotype 7f, Pneumococcal Polysaccharide Serotype 8, Pneumococcal polysaccharide serotype 9v, Pneumococcal Polysaccharide Serotype 10A, Pneumococcal Polysaccharide Serotype 11A, Pneumococcal Polysaccharide Serotype 12F, Pneumococcal polysaccharide serotype 14, Pneumococcal Polysaccharide Serotype 15B, Pneumococcal polysaccharide serotype 18c, Pneumococcal Polysaccharide Serotype 19A, Pneumococcal polysaccharide serotype 19f, Pneumococcal Polysaccharide Serotype 22F, Pneumococcal polysaccharide serotype 23f, Pneumococcal Polysaccharide Serotype 33F
- Dosage Form
- Suspension for injection
- Licence number
- EU/1/21/1612/001-006
- Licence holder
- Pfizer Europe MA EEIG
Product documents
Licence information
- ATC code
- J07AL02 pneumococcus, purified polysaccharides antigen conjugated
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 14/02/2022